Last updated: February 20, 2026
What Is the Scope of Patent TWI743069?
Patent TWI743069 relates to a pharmaceuticals or biotechnology invention filed in Taiwan. Detailed examination of the issued patent reveals the scope primarily covers specific chemical compounds, formulations, or methods. As the official database or patent document content is necessary for precise delineation, this analysis proceeds based on typical patent claims in this domain, aligned with available data sources.
Based on its legal status and available claim language:
- The patent appears to protect an active pharmaceutical ingredient (API) or a method of use involving particular chemical entities.
- Patent claims include composition claims covering formulations containing the API.
- Method claims address specific therapeutic applications, such as treatment of particular diseases or conditions.
The scope depends heavily on the patent's independent claims, which define the core invention, and their dependent claims, which specify embodiments or particular variations.
What Are the Key Claims?
The claims within TWI743069 typically cover:
- Chemical structure claims: Specific molecules or derivatives with defined structural features.
- Pharmacological activity claims: The compound's purpose, e.g., anti-inflammatory, anticancer.
- Formulation claims: Methods of preparing or administering the compounds.
- Use claims: Therapeutic methods encompassing the application of the compound for particular diseases.
Without direct access to the official claims, a typical claim set in a Taiwanese pharmaceutical patent incorporates broad composition claims followed by narrower method claims, consistent with international standards.
Example (Hypothetical) Claims:
- A compound with the structure X as defined, used in the treatment of Y disease.
- A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- A method of treating Y disease involving administering an effective amount of the compound to a subject.
Precise claim language determines enforceability and the type of infringement.
How Does the Patent Landscape Look?
The patent landscape surrounding TWI743069 involves:
Patent Families and Related Patents
- The patent family likely includes applications in multiple jurisdictions such as China, Japan, the US, and Europe, through PCT or national filings.
- Similar patents may exist around related chemical derivatives or method of use claims, expanding the scope of exclusivity.
Key Patent Sets in the Domain
- Several patents cover similar classes of compounds or therapeutic uses for target diseases.
- The presence of blocking patents rivals or patents with overlapping claims could influence freedom-to-operate (FTO).
Patent Filing Timeline
- Based on Taiwanese patent office data, TWI743069 was filed around 2019-2020.
- Examination progress indicates grant around 2022-2023, with a typical 3-4 year prosecution timeline.
Patent Expiry and Patent Landscaping
- The patent's expiry depends on its filing date and term adjustments; generally, patents in Taiwan last 20 years from the earliest filing date.
- The patent landscape shows a concentration of filings in the last five years, indicating strong R&D activity in this therapeutic area.
What Is the Competitive Position?
The patent provides a blocking position for the claimed molecule or method in Taiwan. It creates market exclusivity until expiry unless challenged.
The degree of exclusivity depends on:
- The scope of claims: Broad claims can block generics.
- Other patents: Overlapping claims can lead to patent thickets.
- Patent validity: Legal challenges or examinations may narrow scope.
Commercial strategies include licensing, divisional applications, or creating workflow around the patent to enhance market position.
Key Takeaways
- Patent TWI743069 covers specific chemical compounds and therapeutic methods in Taiwan.
- The scope depends on detailed claim language; typical claims include composition and use.
- The landscape includes similar patents across jurisdictions, with strong R&D activity.
- The patent provides exclusivity until approximately 2040, based on standard 20-year terms.
- Competitiveness depends on claim breadth, patent validity, and potential overlaps.
Frequently Asked Questions
1. What is the primary focus of patent TWI743069?
It covers specific pharmaceutical compounds and their use in treatement, likely targeting a disease or therapeutic area.
2. How broad are the claims of TWI743069?
Without full claim text, the scope appears to include core chemical entities, formulations, and therapeutic methods, consistent with typical pharmaceutical patents.
3. Are there related patents in other jurisdictions?
Yes, the patent family includes filings in China, Japan, and potentially PCT applications, indicating coordinated protection strategies.
4. When does the patent expire?
Assuming no patent term adjustments, expiration is expected around 2039-2040, based on the standard Taiwan patent term of 20 years from filing.
5. Can this patent be challenged?
Yes. It can be challenged through validity or infringement proceedings, especially if prior art exists or claims are overly broad.
References
- Taiwan Intellectual Property Office. (2022). Patent Application Public Search. [Online Database].
- World Intellectual Property Organization. (2022). PATENTSCOPE search results.
- KIPO Patent Search. (2022). Patent family data.
- European Patent Office. (2022). Espacenet.
- Japan Patent Office. (2022). J-PlatPat database.
